12:00 AM
 | 
Aug 28, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

NC100182: Began Phase I trial

Nycomed Amersham plc (LSE:NAM; OSE:NYA; NYE), Little Chalfont, U.K.
Product: NC100182
Business: Diagnostics/Imaging
Therapeutic Category: Test
Target: NA
Description: Magnetic resonance imaging (MRI)...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >